TRVN logo

Trevena (TRVN)

Profile

Full Name

Trevena, Inc.

Ticker Symbol

TRVN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 31, 2014

Indexes

Not included

Website

http://www.trevena.com

Employees

23

Key Details

Price

$1.11(-1.77%)

Market cap

$958.82K(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$3.13M(+847.61% YoY)

Annual EPS

-$79.00(+58.37% YoY)

PE ratio

-

Next earnings date

Apr 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.11
TRVN price is $1.11

30-Day Relative Volume

1.43
TRVN 30-day relative volume is 1.43

Price Performance

Price Most recent change

-1.77%
TRVN price was down -1.77% on Apr 14, 2025

Price YTD change

-26%
TRVN price is down -26% since January 1st

Price 1-year change

-88.67%
TRVN price is down -88.67% year-on-year

Price 3-year change

-99.56%
TRVN price is down -99.56% over the past 3 years

Price Range

Price All-time high

$8312.50
TRVN price is currently -99.99% below its historical high of $8312.50

Price 3-year low

$0.19
TRVN price is currently +481.15% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$958.82K
TRVN market capitalization is $958.82 thousand

Market cap 3-year change

-98.55%
TRVN market capitalization is down -98.55% over the past 3 years

Market cap All-time high

$655.69M
TRVN market capitalization is currently -99.85% below its historical high of $655.69 million

Market cap sector rank

3.78%
TRVN market capitalization is higher than 3.78% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+17.88%
TRVN shares outstanding is up +17.88% year-on-year

Shares Outstanding 3-Year Change

+226.21%
TRVN shares outstanding is up +226.21% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.13
TRVN beta is 1.13

200-day SMA

$2.82
TRVN price is currently -60.64% below its 200-day simple moving average

50-day SMA

$1.49
TRVN price is currently -25.42% below its 50-day simple moving average

RSI

37.56
TRVN 14-day relative strength index is 37.56

Volume

1.43
TRVN 30-day relative volume is 1.43

ATR

$0.10
TRVN average true range is $0.10

10-day Historical Volatility

106.47%
TRVN 10-day historical volatility is 106.47%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$3.13M
TRVN annual revenue is $3.13 million

Revenue Analysts estimate

$628.00K
TRVN annual revenue is currently +397.61% higher than the consensus analysts' forecast

Revenue 1-year change

+847.61%
TRVN annual revenue is up +847.61% year-on-year

Revenue Sector rank

18.59%
TRVN annual revenue is higher than 18.59% of companies in Healthcare sector

EPS

EPS

-$79.00
TRVN annual earnings per share is -$79.00

EPS Analysts estimate

-$23.04
TRVN annual earnings per share is currently +242.88% higher than the consensus analysts' forecast

EPS 1-year change

+58.37%
TRVN annual earnings per share is up +58.37% year-on-year

EPS Sector rank

2.73%
TRVN annual earnings per share is higher than 2.73% of companies in Healthcare sector

Profit

Gross profit

$1.46M
TRVN annual gross profit is $1.46 million

Gross margin

46.56%
TRVN annual gross profit margin is 46.56%

Operating profit

-$35.29M
TRVN annual operating income is -$35.29 million

Operating margin

-1129.22%
TRVN annual operating profit margin is -1129.22%

Net income

-$40.29M
TRVN annual net profit is -$40.29 million

Net margin

-1289.25%
TRVN annual net profit margin is -1289.25%

Expenses

Total expenses

$38.41M
TRVN annual total expenses is $38.41 million

Operating expenses

$36.74M
TRVN annual total operating expenses is $36.74 million

Cost of goods sold

$1.67M
TRVN annual cost of goods sold is $1.67 million

Selling, general & administrative expenses

$20.41M
TRVN annual SGA is $20.41 million

Depreciation and amortization

$334.00K
TRVN annual depreciation & amortization is $334.00 thousand

Interest expense

$3.64M
TRVN annual interest expense is $3.64 million

Income tax

$318.00K
TRVN annual income tax is $318.00 thousand

EBIT & EBITDA

EBIT

-$36.33M
TRVN annual earnings before interest & taxes is -$36.33 million

EBITDA

-$35.99M
TRVN annual EBITDA is -$35.99 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$40.60M
TRVN annual total assets is $40.60 million

Non current assets

$5.40M
TRVN annual long term assets is $5.40 million

Current assets

$35.20M
TRVN annual total current assets is $35.20 million

Cash and cash equivalents

$32.98M
TRVN annual cash & cash equivalents is $32.98 million

Accounts receivable

-
TRVN annual accounts receivable value is unknown

Inventory

$0.00
TRVN annual inventory is $0.00

Liabilities

Total liabilities

$48.26M
TRVN annual total liabilities is $48.26 million

Long term liabilities

$40.71M
TRVN annual total long term liabilities is $40.71 million

Current liabilities

$7.55M
TRVN annual total current liabilities is $7.55 million

Accounts payable

$2.30M
TRVN annual accounts payable is $2.30 million

Debt

Total debt

$36.24M
TRVN annual total debt is $36.24 million

Total debt 1-year change

+83.38%
TRVN annual total debt is up +83.38% year-on-year

Long term debt

$35.23M
TRVN annual long term debt is $35.23 million

Short term debt

$1.01M
TRVN annual short term debt is $1.01 million

Equity & Capital

Shareholders equity

-$7.66M
TRVN annual stockholders equity is -$7.66 million

Book value

-$7.66M
TRVN annual book value is -$7.66 million

Retained earnings

-$588.06M
TRVN annual retained earnings is -$588.06 million

Working capital

$27.65M
TRVN annual working capital is $27.65 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$33.03M
TRVN annual cash flow from operations is -$33.03 million

Cash from operations 1-year change

+35.83%
TRVN annual cash flow from operations is up +35.83% year-on-year

Cash from investing

-$41.00K
TRVN annual cash flow from investing activities is -$41.00 thousand

Cash from investing 1-year change

-327.78%
TRVN annual cash flow from investing activities is down -327.78% year-on-year

Cash from financing

$26.31M
TRVN annual cash flow from financing activities is $26.31 million

Cash from financing 1-year change

+11.94%
TRVN annual cash flow from financing activities is up +11.94% year-on-year

CAPEX

CAPEX

$41.00K
TRVN annual capital expenditures is $41.00 thousand

CAPEX 1-year change

+46.43%
TRVN annual capital expenditures is up +46.43% year-on-year

Free Cash Flow

Free cash flow

-$33.08M
TRVN annual free cash flow is -$33.08 million

Free cash flow 1-year change

+35.78%
TRVN annual free cash flow is up +35.78% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

46.56%
TRVN annual gross profit margin is 46.56%

Operating margin

-1129.22%
TRVN annual operating profit margin is -1129.22%

Net margin

-1289.25%
TRVN annual net profit margin is -1289.25%

ROA & ROE

ROA

-90.25%
TRVN annual return on assets is -90.25%

ROE

-1014.58%
TRVN annual return on equity is -1014.58%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
TRVN price to earnings ratio value is unknown

PE ratio Sector rank

-
TRVN price to earnings ratio is unknown

PB Ratio

PB ratio

-0.04
TRVN price to book ratio is -0.04

PB ratio Sector rank

13.91%
TRVN price to book ratio is higher than 13.91% of companies in Healthcare sector

PS Ratio

PS ratio

1.76
TRVN price to sales ratio is 1.76

PS ratio Sector rank

40.38%
TRVN price to sales ratio is higher than 40.38% of companies in Healthcare sector

Enterprise value

Enterprise value

$25.06M
TRVN enterprise value is $25.06 million

Enterprise value Sector rank

34.46%
TRVN enterprise value is higher than 34.46% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.82
TRVN EV/EBITDA is -0.82

EV/EBITDA Sector rank

46%
TRVN EV/EBITDA is higher than 46% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.66
TRVN annual current ratio is 4.66

Quick ratio

4.66
TRVN annual quick ratio is 4.66

Leverage

Debt to equity

-4.02
TRVN annual debt to equity ratio is -4.02

Interest coverage ratio

-9.97
TRVN annual interest coverage ratio is -9.97

Risk & Stability

Piotroski F-Score

2
TRVN piotroski f-score is 2

Altman Z-Score

-22.32
TRVN altman z-score is -22.32

Analyst ratings

Recent major analysts updates

Nov 14, 24 HC Wainwright & Co.
Neutral
May 16, 24 HC Wainwright & Co.
Buy
Apr 2, 24 HC Wainwright & Co.
Buy
Mar 11, 24 HC Wainwright & Co.
Buy
May 17, 23 JMP Securities
Market Outperform
Mar 31, 23 JMP Securities
Market Outperform
Mar 31, 23 HC Wainwright & Co.
Buy
May 12, 22 HC Wainwright & Co.
Buy
Mar 15, 21 Oppenheimer
Perform
Sep 14, 20 Guggenheim
Buy

Institutional Ownership

Similar stocks

BIOR logo
Biora Therapeutics (BIOR)
NEPT logo
Neptune Wellness Solutions (NEPT)
APDN logo
Applied DNA Sciences (APDN)
WINT logo
Windtree Therapeutics (WINT)
DYNT logo
Dynatronics (DYNT)
AFIB logo
Acutus Medical (AFIB)
ATXI logo
Avenue Therapeutics (ATXI)
BDRX logo
Biodexa Pharmaceuticals (BDRX)
VIRX logo
Viracta Therapeutics (VIRX)
  • What is the ticker symbol for Trevena?
  • Does Trevena pay dividends?
  • What sector is Trevena in?
  • What industry is Trevena in?
  • What country is Trevena based in?
  • When did Trevena go public?
  • Is Trevena in the S&P 500?
  • Is Trevena in the NASDAQ 100?
  • Is Trevena in the Dow Jones?
  • When was Trevena's last earnings report?
  • When does Trevena report earnings?
  • Should I buy Trevena stock now?

What is the ticker symbol for Trevena?

The ticker symbol for Trevena is NASDAQ:TRVN

Does Trevena pay dividends?

No, Trevena does not pay dividends

What sector is Trevena in?

Trevena is in the Healthcare sector

What industry is Trevena in?

Trevena is in the Biotechnology industry

What country is Trevena based in?

Trevena is headquartered in United States

When did Trevena go public?

Trevena's initial public offering (IPO) was on January 31, 2014

Is Trevena in the S&P 500?

No, Trevena is not included in the S&P 500 index

Is Trevena in the NASDAQ 100?

No, Trevena is not included in the NASDAQ 100 index

Is Trevena in the Dow Jones?

No, Trevena is not included in the Dow Jones index

When was Trevena's last earnings report?

Trevena's most recent earnings report was on Nov 7, 2024

When does Trevena report earnings?

The next expected earnings date for Trevena is Apr 15, 2025

Should I buy Trevena stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page